News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
ZARS Pharma IPO Postponed for Next Week
September 21, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK, Sept 20 (Reuters) - Zars Pharma Inc, a Salt Lake City pharmaceutical company, has postponed its initial public offering to next week, an underwriter said on Thursday.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
IPOs
UPDATE: MapLight Seeks $227M IPO for Neuropsych Portfolio
October 7, 2025
·
3 min read
·
Tristan Manalac
Mergers & acquisitions
How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio
October 2, 2025
·
3 min read
·
Annalee Armstrong
Mergers & acquisitions
Q3 Saw Some of the Highest-Value Biopharma Acquisitions of the Year So Far
October 1, 2025
·
2 min read
·
Annalee Armstrong
Mergers & acquisitions
The Top Big Pharmas Have $1.2T in Stretch M&A Firepower Available
October 1, 2025
·
6 min read
·
Annalee Armstrong
